COMPANY
Phenomix Sciences
NIH awards 3
- NIH award 5R44DK138619-03 FY2026: $348,022 awarded for that fiscal year; activity R44 (SBIR); PI BAGNALL, MARK; recipient as written: PHENOMIX SCIENCES, LLC, Menlo Park, CA. A NOVEL PRECISION MEDICINE APPROACH FOR OB source ↗
- NIH award 5R44DK138619-02 FY2025: $995,866 awarded for that fiscal year; activity R44 (SBIR); PI BAGNALL, MARK; recipient as written: PHENOMIX SCIENCES, LLC, Menlo Park, CA. A NOVEL PRECISION MEDICINE APPROACH FOR OB source ↗
- NIH award 1R44DK138619-01 FY2024: $996,003 awarded for that fiscal year; activity R44 (SBIR); PI BAGNALL, MARK; recipient as written: PHENOMIX SCIENCES, LLC, Menlo Park, CA. A NOVEL PRECISION MEDICINE APPROACH FOR OB source ↗
Funding and NIH signals
- SEC Form D raise Raised $2.5M (Form D filed Dec 29, 2025). SEC Form D 0001966746-25-000002 (Dec 29, 2025)
Evidence (1 event)
- Dec 29, 2025 · SEC Form D 0001966746-25-000002
Name of Issuer: Phenomix Sciences, Inc.; CIK: 1966746; Address: Menlo Park, CA; Submission type: D; Filing date: 2025-12-29; Industry Group: Other Health Care; Date of First Sale: 2025-12-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000004; Total Amount Sold: 2500002; Federal exemptions: 06b
- Dec 29, 2025 · SEC Form D 0001966746-25-000002
- NIH award NIH awarded $348K (SBIR Phase II 5R44DK138619-03, continuation, notice May 7, 2026). NIH RePORTER 5R44DK138619-03 (May 7, 2026)
Evidence (1 event)
- May 7, 2026 · NIH RePORTER 5R44DK138619-03
Organization: PHENOMIX SCIENCES, LLC; City/State: Menlo Park, CA; Project number: 5R44DK138619-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-07; FY total cost (award amount): 348022; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: A NOVEL PRECISION MEDICINE APPROACH FOR OBESITY: A RANDOMIZED, MULTI-CENTER TRIAL; Organization type: Domestic For-Profits
- May 7, 2026 · NIH RePORTER 5R44DK138619-03